Andrew Sfekas provides financial and economic analysis in complex matters involving antitrust and competition in healthcare and life sciences markets. Dr. Sfekas has particular expertise with pharmaceuticals and issues arising in the hospital industry, notably pricing, consumer choice, and innovation. Dr. Sfekas supports experts and attorneys across all phases of commercial litigation and regulatory investigations.

Cornell University, Ph.D. University of Maryland, B.A.